The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high- grade astrocytoma

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 3, 1999, Pages 535-543

  Kleinberg, Lawrence ^a   Grossman, Stuart A ^a   Piantadosi, Steven ^a   Zeltzman, Michel ^a   Wharam, Moody ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Anaplastic astrocytoma; BCNU; Chemotherapy; Cisplatin; Combined modality therapy; Glioblastoma; Leukopenia; Radiotherapy; Toxicity

Indexed keywords

CARMUSTINE; CISPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; GLIOBLASTOMA; HUMANS; LEUKOPENIA; LYMPHOCYTES; MIDDLE AGED; RADIATION DOSAGE; SURVIVAL ANALYSIS; THROMBOCYTOPENIA;

EID: 0033041822     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00060-7     Document Type: Article

References (25)

1. Grossman S.A., Wharam M., Sheidler V., et al. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol. 15:1997;2596-2603.
2. Leggett R.W., Williams L.R. A proposed blood circulation model for reference man. Health Phys. 69:1995;187-201.
3. Leggett R.W., Williams L.R. Suggested reference values for regional blood volumes in humans. Health Phys. 60:1991;139-154.
4. Ekstrand K.E., Dixon R.L., Plunkett S., et al. The calculation of the dose to lymphocytes in external beam. Radiat Res. 85:1981;399-407.
5. Fetell M.R., Grossman S.A., Fisher J., et al. Pre-irradiation paclitaxel in glioblastoma multiforme Efficacy, pharmacology, and drug interactions . J Clin Oncol. 15:1997;3121-3128.
6. Hochberg F, Grossman SA, Mikkelsen T; et al. Efficacy of 9-Aminocamptothecin (9-AC) in adults with newly diagnosed glioblastoma multiforme (GBM) and recurrent high grade astrocytomas (HGA). NABTT CNS Consortium, ASCO, 1987.
7. Johnson D.H., Bass D., Einhorn L.H., et al. Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer A randomized trial of the southeastern cancer study group . J Clin Oncol. 11:1993;1223-1229.
8. Perry M.C., Eaton W.L., Propert K.J., et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 316:1987;912-918.
9. Bunn P.A. Jr, Crowley J., Kelly K., et al. Chemotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer A prospective phase III randomized study of the southwest oncology group . J Clin Oncol. 13:1995;1632-1641.
10. Abrams R.A., Johnston-Early A., Dramer C., et al. Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung. Cancer Res. 41:1981;35-41.
11. Beiler D.D., Kane R.C., Bernath A.M., et al. Low dose elective brain irradiation in small cell carcinoma of the lung. Int J Radiot Oncol Biol Phys. 5:1979;941-945.
12. Hendry J.J., Roberts S.A. Analysis of dose-incidence relationships for marrow failure in different species, in terms of radiosensitivity of tissue-rescuing units. Radiat Res. 122:1990;155-160.
13. Baird M.C., Hendry J.H., Testa N.G. The radiosensitivity of human haemopoietic progenitor cells. Int J Radiat Biol. 56:1989;617-621.
14. Nothdurft W., Fliedner T.M. The response of the granulocytic progenitor cells (CFU-C) of blood and bone marrow in dogs exposed to low doses of X irradiation. Radiat Res. 89:1982;38-52.
15. Nothdruft W., Steinbach K.-H., Fliedner T.M. In vitro studies on the sensitivity of canine granulopoietic progenitor cells (GM-CFC) to ionizing radiation Differences between steady state GM-CFC from blood and bone marrow . Int J Radiat Biol. 43:1983;133-140.
16. McCredie J.A., Inch W.R., Sutherland R.M. Effect of postoperative radiotherapy on peripheral blood lymphocytes in patients with carcinoma of the breast. Cancer. 29:1972;349-367.
17. Uh S., Lee S.M., Kim H.T., et al. The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma. Chest. 105:1994;132-137.
18. To L.B., Shepperd K.M., Haylock D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells form the peripheral blood. Exp Hematol. 18:1990;442-447.
19. Abrams R.A., McCormack D., Bowles C., et al. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest. 67:1981;1392-1399.
20. Bunn P.A. Jr, Crowley J., Kelly K., et al. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer A prospective phase III randomized study of the southwest oncology group . J Clin Oncol. 13:1995;1632-1641.
21. Meropol J.N., Miller L.L., Korn E.L., et al. Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst. 84:1992;1201-1203.
22. Welte K., Bonilla M.A., Gillio A.P., et al. Recombinant human granulocyte colony-stimulating factor effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med. 165:1987;941-948.
23. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. N Engl J Med. 327:1992;99-106.
24. Bensinger W.I., Longin K., Appelbaum F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating fact (rhg-CSF) An analysis of factors correlating with the tempo of engraftment after transplantation . Br J Hematol. 87:1994;825-831.
25. Bolwell B.J., Fishleder A., Andresen S.W., et al. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation Parameters affecting bone marrow engraftment . Bone Marrow Transpl. 12:1993;609-614.